Etiqueta: stem cells
-
New Study Sheds Light on the Mysteries of the Bone Marrow Stem Cell Niche
Researchers at the Linheng Li Lab of the Stowers Institute have identified the precise location of the bone marrow stem cell niche, thereby solving a widely regarded mystery.
-
ALS Improved by Antioxidants
Scientists at the Salk Institute have demonstrated with human stem cells that an antioxidant commonly found in plants can improve amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
-
Osiris Completes Enrollment in First Worldwide Phase III Stem Cell Trial
The adult stem cell company Osiris Therapeutics accomplishes an historic milestone by completing patient enrollment in the first phase III clinical trial ever to be conducted with adult stem cells in the treatment of Graft versus Host Disease.
-
Adult Stem Cell Therapy Rejuvenates Aging Pooch
Once again, man’s best friend proves that adult stem cells are the best therapy of choice for discriminating patients.
-
Scientists Prove Endothelial Cells are the Source of Blood Stem Cells
Researchers at UCLA have settled a long-standing debate by discovering exactly when and where the body manufactures blood stem cells.
-
Adult Stem Cells from Bone Marrow Offer Therapy for Skin Disorder
Adult stem cells derived from bone marrow have been shown to be therapeutic in the treatment of a rare skin disease.
-
Caveat Emptor: New Guidelines are Issued to Protect Patients Against Bogus Stem Cell Therapies
Although legitimate adult stem cell therapies are already available, there is also no shortage of bogus stem cell therapies which erroneously claim to offer benefits.
-
Adult Stem Cells from Skeletal Muscle Repair Heart Tissue and Offer a Wide Range of Other Therapeutic Applications
Researchers at Children’s Hospital in Pittsburgh announce that human adult stem cells derived from skeletal muscle have successfully repaired damaged heart tissue more effectively than previously studied therapies.
-
European Agency Rules Against Human Embryonic Stem Cell Patents
European regulators have passed a controversial ruling that forbids the issuing of patents for human embryonic stem cells.